Figure 3.1. Recommendations for switching P2Y12 inhibitors in the first 30 days after acute coronary syndrome. A loading dose of the new agent is routinely recommended. *If prasugrel or ticagrelor therapy is being de-escalated due to bleeding or an increased risk of bleeding, only a maintenance dose of clopidogrel can be considered. Adapted from Valgimigli et al.451.
